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To identify a determinant of human H3 hemagglutinin (HA) amino acid residues linked to the rec-
ognition of molecular species of sialic acid, we generated six mutant viruses possessing either the
wild-type HA gene from A/Memphis/1/71 (H3N2) or a genetically single-mutated HA gene at position
137, 144, 155, 158 or 193 from a genetic backbone of A/WSN/33 (H1N1) by reverse genetics. We eval-
uated the binding ability with four types of synthetic sialylglycolipids. The results indicate that the
amino acid substitutions Thr155 to Tyr and Glu158 to Gly in H3 HA facilitate virus binding to N-gly-
colylneuraminic acid.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction conjugates containing Neu5Gc are expressed in many animal tis-Inﬂuenza virus hemagglutinin (HA) attaches to sialoglycoconju-
gates (glycoproteins and glycolipids containing sialic acid) on the
host cell surface to initiate infection. Binding speciﬁcity of inﬂuenza
Avirus (IAV) for sialyloligosaccharidemoietieson the cell surface is a
critical factor for acquiring transmissionability to differenthost spe-
cies [1,2]. Many derivatives of sialic acid (about 30 species) are
known to exist in organisms ranging from bacteria to mammals
[3]. Two major molecular species of sialic acid are 5-N-acetylneu-
raminic acid (Neu5Ac) and 5-N-glycolylneuraminic acid (Neu5Gc),
which are chemically distinguished by a functional group at the C-
5 position. Neu5Gc is derived from enzymatic hydroxylation of the
N-acetyl group of Neu5Ac by CMP-Neu5Ac hydroxylase [4]. Glyco-chemical Societies. Published by E
tination unit; IAV, inﬂuenza A
5-N-glycolylneuraminic acid;
Biochemistry, University of
422-8526, Japan. Fax: +81 54
uzuki).sues, whereas they cannot be synthesized in normal human tissues
owing to a lack of the N-terminus of the CMP-Neu5Ac hydroxylase
gene [5]. Determination of the molecular mechanisms of sialic acid
recognition by inﬂuenza virus will help to clarify the roles of sialic
acids in cell tropism and host transmission of IAV, leading to useful
information for the development of anti-inﬂuenza virus agents.
In our previous study, virus overlay assays of nine human IAV
strains (subtype H3N2) against four types of sialylglycolipids that
had varied molecular species of a terminal sialic acid and sialyl-
linkages showed that amino acid substitution at position 137,
144, 155, 158 or 193 of H3 HA may play a critical role in the recog-
nition of Neu5Ac and Neu5Gc [6]. We therefore generated recom-
binant viruses from a genetic background of A/WSN/33 (H1N1)
that included wild-type HA and ﬁve mutant H3 HAs in which
one speciﬁc amino acid point mutation from A/Memphis/1/71
(H3N2) H3 HA was introduced by using site-speciﬁc mutagenesis.
We showed that single amino acid substitutions of H3 HA at posi-
tion 155 from Thr to Tyr and at position 158 from Glu to Gly play a
critical role in recognition of two major molecular species of sialic
acids.lsevier B.V. All rights reserved.
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2.1. Sialylglycolipids
The synthetic sialylglycolipids commonly had Galb1-4Glc-
NAcb1-3Galb1-4Glc as a core structure, a sialic acid residue
(Neu5Ac or Neu5Gc) linked to a non-reducing galactose terminal
and the ceramide portion substituted by a branched hydrocarbon
chain containing 30 carbons. All of the compounds were essentially
synthesized by the procedure described by Kameyama et al. [7].
Detailed structures of the four synthetic sialylglycolipids used
(IV3(Neu5Ac)nLc4B30, IV6(Neu5Ac)nLc4B30, IV3(Neu5Gc)nLc4B30,
and IV6(Neu5Gc)nLc4B30) are given in [6].
2.2. Viruses
polI-Mem71HA was generated by insertion of human IAV
A/Memphis/1/71 (H3N2) HA gene (accession number: AB298687)
into the BsmBI restriction sites of pHH21 plasmid. Six IAVs were
generated by a reverse genetics system [8]. Each transfectant virus
possessed wild-type HA from A/Memphis/1/71 (H3N2) strain or aFig. 1. Binding of reverse genetics IAVs to synthetic sialylglycolipids in virus overlay assa
with TLC. (A) A/Memphis/1/71 (H3N2); (B) WT; (C) N137Y; (D) G144D; (E) T155Y
IV6(Neu5Ac)nLc4B30; (3) IV3(Neu5Gc)nLc4B30; and (4) IV6(Neu5Gc)nLc4B30.
Table 1
Comparison of HA amino acid residues involved in recognition of molecular species of a t
Virus (H3N2) Amino acid residue at position
137 144 155 158
A/Memphis/1/71 Asn Gly Thr Glu
A/Hong Kong/1/68 Asn Gly Thr Gly
A/Aichi/2/68 Asn Asp Thr Gly
A/Memphis/102/72 Asn Asp Tyr Gly
A/Tokyo/6/73 Asn Asp Tyr Gly
A/Kumamoto/55/76 Ser Asp Tyr Gly
A/Yamanashi/2/77 Ser Asp Tyr Gly
A/Texas/1/77 Tyr Asp Tyr Glu
A/Bangkok/1/79 Tyr Asp Tyr Glu
Binding reactivity of H3 IAV strains with each sialylglycolipid is expressed as positive (ope
Neu5Aca2,3, IV3(Neu5Ac)nLc4B30; Neu5Aca2,6, IV6(Neu5Ac)nLc4B30; Neu5Gca2,3, IV3(single amino acid mutant of the HA at position 137 from Asn to
Tyr (N137Y), at position 144 from Gly to Asp (G144D), at position
155 from Thr to Tyr (T155Y), at position 158 from Glu to Gly
(E158G), or at position 193 from Ser to Asn (S193N) and all remain-
ing genes from A/WSN/33 (H1N1). HA genes were mutated accord-
ing to the procedure of the QuickChange II Site-directed
Mutagenesis kit (Stratagene, La Jolla, CA) by using respective mu-
tated primer pairs, 50-CAGAATGGGGGAAGCTATGCTTGCAAAAG-30
and 50-CTTTTGCAAGCATAGCTTCCCCCATTCTG-30 for N137Y muta-
tion, 50-GCAAAAGGGGACCTGATAGCGGTTTTTTCAG-30 and 50-CTG
AAAAAACCGCTATCAGGTCCCCTTTTGC-30 for G144D mutation, 50-
CAGTAGACTGAACTGGTTGTACAAATCAGAAAGC-30 and 50-GCTTTC
TGATTTGTACAACCAGTTCAGTCTACTG-30 for T155Y mutation, 50-
GTTGACCAAATCAGGAAGCACATATCCAG-30 and 50-CTGGATATGT
GCTTCCTGATTTGGTCAAC-30 for E158G mutation, or 50-CCAAGAA-
CAAACCAACCTGTATGTTCAAGC-30 and 50-GCTTGAACATACAGGTT
GGTTTGTTCTTGG-30 for S193N mutation. All viruses were grown
in 10-day-old embryonated chicken eggs, concentrated, and puri-
ﬁed by sedimentation through 20% glycerol. Viral hemagglutina-
tion units (HAU) were determined at 4 C in microtiter plates as
previously described [9]. These mutations of HA genes wereys. Binding ability of each recombinant IAV was determined by a virus overlay assay
; (F) E158G; (G) S193N; and (H) no virus. Lanes: (1) IV3(Neu5Ac)nLc4B30; (2)
erminal sialic acid and sialyl-linkages by human H3 IAVs.
IAV binding with synthetic sialylglycolipids
193 Neu5Ac Neu5Gc
a2,3 a2,6 a2,3 a2,6
Ser  s  
Ser s s s s
Ser s s s s
Ser  s  s
Asn  s  s
Asp s s s s
Asp s s s s
Asn  s  s
Asn  s  s
n circle) and negative (closed circle) from the result of virus overlay assay in Ref. [6].
Neu5Gc)nLc4B30; Neu5Gca2,6, IV6(Neu5Gc)nLc4B30.
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(Applied Biosystems Inc., Foster City, CA).
2.3. Antibodies
Rabbit anti-IAV antibodies were prepared as described in [10].
Anti-HA monoclonal antibody (MAb) was generated from mice
raised against A/Memphis/1/71 (H3N2) by a previously described
[11].
2.4. Virus overlay assay
Synthetic sialylglycolipids (1 nmol) were developed in silica gel
thin-layer chromatography (TLC) plates (Polygram Sil G: Nagel,
Germany) with chloroform/methanol/12 mM aqueous MgCl2
(65/35/8, v/v/v). The TLC plates were immersed in phosphate-
buffered saline (PBS) (pH 7.2, 131 mM NaCl, 14 mM Na2HPO4,
1.5 mM KH2PO4, and 2.7 mM KCl) containing 1% egg albumin and
1% polyvinylpyrrolidone for 2 h at room temperature and incu-
bated with each IAV suspension (210 HAU) for 12–16 h at 4 C.
The plates were then incubated with rabbit anti-IAV antibodies
for 2 h at 4 C, followed by horseradish peroxidase-conjugated pro-
tein A. Finally, the plates were visualized as described in [1].
2.5. Solid-phase binding assay
Synthetic sialylglycolipids were serially diluted in ethanol from
a concentration of 12.5 pmol/10 ll. Ten microliters of each diluted
sialylglycolipid was placed into a well of a microplate (1  8 Strip-
well plate, Corning Incorp. Life Sciences, Lowell, MA) until the eth-
anol had completely dried up. After exposure of the plate to
ultraviolet light (254 nm) for 1 min, each well was blocked with
250 ll/well of PBS containing 1% lipid-free BSA overnight at 4 C.
After washing with 0.01% Tween20-PBS, the wells were incubated
with 50 ll/well of IAV suspension (210 HAU) at 4 C for 12 h. After
washing, the wells were incubated with mouse anti-HA MAb, fol-
lowed by horseradish peroxidase-conjugated anti-mouse IgG + M.
Finally, the wells were colored as described in [12].Fig. 2. Binding of reverse genetics IAVs to synthetic sialylglycolipids in solid-phase
binding assays. Binding ability of each recombinant IAV was determined by a solid-
phase binding assay. (A) A/Memphis/1/71 (H3N2); (B) WT; (C) N137Y; (D) G144D;
(E) T155Y; (F) E158G; and (G) S193N. Sialylglycolipids: open square,
IV3(Neu5Ac)nLc4B30; closed square, IV6(Neu5Ac)nLc4B30; open circle,
IV3(Neu5Gc)nLc4B30; closed circle, IV6(Neu5Gc)nLc4B30.3. Results and discussion
Our previous study showed that nine human IAV strains
(H3N2) except A/Memphis/1/71 had the ability to bind to both
Neu5Aca2-6Gal and Neu5Gca2-6Gal linkages as summarized in
Table 1 [6]. Comparison of HA amino acid sequences, which are lo-
cated in and close to the receptor-binding pocket, among the
viruses has shown that amino acid substitution at position 137,
144, 155, 158 or 193 of H3 HA may play a critical role in the recog-
nition of Neu5Ac and Neu5Gc. To identify a determinant of HA
amino acid residues related to this recognition, we generated six
infectious reverse genetics viruses possessing the wild-type HA
gene or a genetically single-mutated HA gene of A/Memphis/1/71
from a genetic backbone of A/WSN/33 (H1N1). (Abbreviations of
transfectant viruses are given in Section 2.) We examined the abil-
ity of the viruses to bind to four types of synthetic sialylglycolipids
that had varied molecular species of terminal sialic acids and sial-
yl-linkages by use of virus overlay assays with TLC plates and solid-
phase binding assays with microplates. A/Memphis/1/71 showed
preferential binding to the sialylglycolipid IV6(Neu5Ac)nLc4B30
possessing Neu5Aca2-6Gal linkage but not to other sialylglycoli-
pids (Figs. 1A and 2A). The transfectant virus possessing wild-type
WT HA (WT) preferentially bound to IV6(Neu5Ac)nLc4B30 (Figs. 1B
and 2B). WT also bound to other sialylglycolipids, but the binding
was weak. Parent A/Memphis/1/71 strain did not show binding to
the sialylglycolipids except IV6(Neu5Ac)nLc4B30 on virus overlayassay. The discrepancy in the binding pattern between WT
and A/Memphis/1/71 may be due to matrix protein 1 (M1) of
A/WSN/33, which affects binding afﬁnity by interaction with HA
at the inner membrane of the virus envelope [13]. N137Y and
S193N exhibited the same binding pattern as that of A/Memphis/
1/71 strain (Figs. 1C, G and 2C, G). G144D showed no binding activ-
ity in the virus overlay assay (Fig. 1D). The binding ability of G144D
was therefore evaluated by use of a solid-phase binding assay.
G144D preferentially bound to IV6(Neu5Ac)nLc4B30; however,
the amount of the virus bound to the sialylglycolipids tested was
Fig. 3. The receptor-binding pocket with Neu5Gc. Location of altered residues
within and neighboring the receptor-binding pocket with Neu5Ac. Orange, N137Y;
light blue, G144D; green, T155Y; yellow, E158G; blue, S193N. The arrow indicates
the N-acetyl group of Neu5Ac. The model was generated by using PyMol Molecular
Graphics System 1.1r1 (Delano Scientiﬁc LLC).
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This mutation may lead to signiﬁcant reduction of binding afﬁnity
to sialylglycolipids. T155Y strongly bound to IV6(Neu5Ac)nLc4B30
and also bound to IV6(Neu5Gc)nLc4B30 possessing Neu5Gca2-6Gal
linkage but not to sialylglycolipids possessing Neu5Aca2-3Gal or
Neu5Gca2-3Gal linkages (Figs. 1E and 2E). E158G showed preferen-
tial binding to both IV6(Neu5Ac)nLc4B30 and IV6(Neu5Gc)nLc4B30
regardless of the molecular species of a terminal sialic acid.
E158G also bound to both of the sialylglycolipids possessing
a2-3 linkage, but the binding ability was weaker than that to
a2-6 linkage (Figs. 1F and 2F). The results indicate that the amino
acid substitutions Thr155 to Tyr and Glu158 to Gly in H3 HA facil-
itate virus binding to the sialylglycolipids possessing Neu5Gc. The
distribution of molecular species of sialic acid and sialyl-linkages
vary among animal species and tissues [3,14]. Avian and equine
IAVs preferentially recognize the Neu5Aca2-3Gal linkage, while
human IAVs preferentially recognize the Neu5Aca2-6Gal linkage
[2]. Genome sequences of H3N2 viruses deposited in the GenBank
database indicate that most of the avian viruses possess Gly at
position 158 in H3 HA and many swine viruses possess Tyr at posi-
tion 155 and Gly at position 158. The data suggest that the amino
acid substitutions Thr155 to Tyr and Glu158 to Gly are probably
responsible for the wide binding pattern recognized by IAVs that
potentially infect a variety of animals. Positions of amino acid
alterations on the published three-dimensional structure of
H3HA [15] are shown in Fig. 3.
Anders et al. suggested that amino acid substitution at position
155 from Thr to Tyr played a critical role in recognition of Neu5Gc
by means of hemagglutination of resialylated erythrocytes [16].
The present work is the ﬁrst study to show, by using a reverse
genetics system, that not only residue 155 but also residue 158
in the HA protein contributes to the recognition of molecular spe-
cies of sialic acid. In the transmission of IAVs between ducks and
other animals including pigs, glycoconjugates containing Neu5Gc
in the trachea of the pig and crypt cells of the duck colon may be
utilized as a common receptor that avian, swine, and equine IAVcan recognize [1,6,14,17]. Our ﬁnding will be helpful in under-
standing the signiﬁcance of molecular species of sialic acid for viral
transmission, host range restriction, and pandemics, leading to
useful information for the development of anti-inﬂuenza virus
agents and surveillance of pandemic potential.
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